Drugs derived from activated protein C may limit ischemia an

A University of South Florida Health preclinical study offers molecular insight into how activated protein C (APC) may improve aging patients' tolerance to reperfusion injury – a potentially adverse effect of treatment for ischemic heart disease.

Related Keywords

Oklahoma , United States , Ji Li , Emily Henderson , Scripps Research Institute , Mcmaster University Canada , Department Of Surgery , A University Of South Florida Health , Oklahoma Medical Research Foundation , Health Heart Institute , Circulation Research , Health Morsani College Of Medicine , South Florida Health , Morsani College , Heart Institute , Mcmaster University , Oklahoma Medical Research , Preclinical , Protein , Protein C , Aging , Angioplasty , Anticoagulant , Anti Inflammatory , Balloon Angioplasty , Flood , Fell , Cell Membrane , Hronic , Compound , Coronary Artery Bypass Surgery , Coronary Artery Disease , Drugs , Nzyme , Heart , Heart Attack , Heart Disease , Schemic Heart Disease , Inase , Medicine , Embrane , Muscle , Oxygen , Eceptor , Research , Ignaling Pathway , Stress , Surgery ,